StockData
Praxis Precision Medicines, Inc. logo

Praxis Precision Medicines, Inc. (PRAX) shareholders

PRAXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$305.06−5.21 (-1.68%)

Close on Nov 17, 2026Market cap $8.52BP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
100.0%
34M of 28M shares
Institutional holders
309
60 new, 39 sold out
Net institutional buying
5M
In Q2 2026
Insider trades, 12 months
0 buys · 18 sales
Net sold $11.08M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Janus Henderson Group PLC
Joint filing with Janus Henderson Biotech Innovation Master Fund Ltd (6.20%)
2,763,85912.30%13G (passive) amendmentSep 30, 2025
Abigail P. Johnson
Joint filing with FMR LLC (9.20%)
2,565,8289.20%13G (passive) amendmentSep 30, 2026
Perceptive Life Sciences Master Fund, Ltd.
Joint filing with Perceptive Advisors LLC (7.20%), Joseph Edelman (7.20%)
1,995,9867.20%13G (passive) amendmentDec 31, 2025
Robert Atchinson
Joint filing with Adage Capital Management, L.P. (9.69%), Phillip Gross (9.69%)
1,974,5859.69%13G (passive) amendmentJun 30, 2025
Julian C. Baker
Joint filing with Baker Bros. Advisors LP (6.30%), Baker Bros. Advisors (GP) LLC (6.30%) and 1 more
1,753,1986.30%13G (passive)Mar 31, 2026
Steven A. Cohen
Joint filing with Point72 Asset Management, L.P. (5.90%), Point72 Capital Advisors, Inc. (5.90%)
1,569,3096.10%13G (passive) amendmentDec 31, 2025
Orbis Investment Management Ltd1,526,6805.50%13G (passive) amendmentJun 30, 2026
Vanguard Capital Management1,419,3235.09%13G (passive)Mar 31, 2026
BlackRock, Inc.1,302,4357.30%13G (passive)Sep 30, 2024
Guy Levy
Joint filing with Soleus Capital Master Fund, L.P. (5.00%), Soleus Capital, LLC (5.00%) and 3 more
1,017,7405.00%13G (passive)Mar 18, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of PRAXValueChange% of portfolio
Jupiter Topco LLC3,421,37412.25%$1.15BNew0.47%
FMR LLC2,316,9078.30%$775.68M+155,9640.03%
BlackRock, Inc.2,292,5858.21%$767.53M−32,3440.01%
Perceptive Advisors LLC2,035,9867.29%$681.63M–10.23%
Baker Bros. Advisors LP1,753,1986.28%$586.95M–2.94%
Orbis Allan Gray Ltd1,529,7885.48%$512.16M−942,6921.76%
Vanguard Portfolio Management LLC1,335,1854.78%$447.01M+578,4370.02%
Vanguard Capital Management LLC1,235,2994.42%$413.57M+13,3550.01%
State Street Corp1,026,4433.68%$343.66M+142,2050.01%
Adage Capital Partners Gp, L.L.C.1,015,4803.64%$339.97M+199,7410.48%
Deerfield Management Company, L.P. (Series C)963,3513.45%$322.52M–3.36%
Driehaus Capital Management LLC959,0483.43%$321.08M+9,8231.86%
Price T Rowe Associates Inc /Md/942,9993.38%$315.71M+312,1470.03%
Morgan Stanley854,1123.06%$285.95M+20,6210.02%
Geode Capital Management, LLC748,0392.68%$250.48M+97,1350.01%
Cormorant Asset Management, LP640,0002.29%$214.27M−245,50010.98%
Goldman Sachs Group Inc548,8301.97%$183.74M−161,9040.02%
Bank Of America Corp /De/546,9301.96%$183.11M+12,3260.01%
Invesco Ltd.537,5481.93%$179.97M+476,1510.01%
Hood River Capital Management LLC425,1671.52%$142.34M+66,5491.03%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202630934M100.0%60 / 12293 / 398M3M
Q1 202629132M100.0%80 / 12069 / 337M3M
Q4 202525029M100.0%115 / 8744 / 1510M5M
Q3 202515225M88.5%28 / 5945 / 195M4M
Q2 202514324M86.6%25 / 6535 / 325M4M
Q1 202515023M84.0%34 / 4752 / 456M4M
Q4 202416222M77.8%38 / 5553 / 105M2M
Q3 202413419M67.6%35 / 4345 / 135M4M
Q2 202411318M66.0%38 / 4226 / 356M4M
Q1 202411116M57.9%60 / 2917 / 710M2M
Q4 2023588M28.4%58 / 00 / 08M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

395 funds held PRAX in Q2 2026, 41% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of PRAXValue% of fundAs of
Vanguard Total Stock Market Index Fund885,4113.17%$296.43M0.01%Jun 30, 2026
iShares Russell 2000 ETF653,1102.34%$218.65M0.26%Jun 30, 2026
Vanguard Small-Cap Index Fund639,5782.29%$214.12M0.11%Jun 30, 2026
State Street(R) SPDR(R) S&P(R) Biotech ETF413,7371.48%$138.52M1.29%Jun 30, 2026
Vanguard Small-Cap Value Index Fund405,0161.45%$135.60M0.20%Jun 30, 2026
Janus Henderson Global Life Sciences Fund379,3521.36%$127.00M2.19%Jun 30, 2026
Select Biotechnology Portfolio371,4291.33%$129.99M2.47%May 31, 2026
Janus Henderson Enterprise Fund358,0921.28%$119.89M0.54%Jun 30, 2026
Vanguard Extended Market Index Fund300,8681.08%$100.73M0.10%Jun 30, 2026
Fidelity Small Cap Index Fund274,7660.98%$84.58M0.25%Jul 31, 2026
Janus Henderson Triton Fund247,7530.89%$82.95M1.40%Jun 30, 2026
T. Rowe Price New Horizons Fund, Inc.236,5690.85%$79.20M0.54%Jun 30, 2026
iShares Russell 2000 Growth ETF233,2320.84%$78.08M0.51%Jun 30, 2026
Fidelity Small Cap Growth Fund186,9300.67%$57.54M0.65%Jul 31, 2026
iShares Biotechnology ETF185,0120.66%$61.94M0.68%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Marcio SouzaChief Executive Officer, Director56,4950.20%Jul 8, 2026
Timothy Edwin KellyChief Financial Officer31,1670.11%May 19, 2026
Megan SniecinskiChief Operating Officer28,6640.10%May 19, 2026
Lauren MastrocolaPrincipal Accounting Officer13,5730.05%May 19, 2026
Alex NemiroffGeneral Counsel and Secretary26,0110.09%May 19, 2026
Jill DeSimoneDirector13,8070.05%Jun 26, 2026
Merit Ester CudkowiczDirector1,3710.00%Jun 12, 2026
Jeffrey B. KindlerDirector2,5370.01%Jun 12, 2026
William D. YoungDirector3,2690.01%Jun 12, 2026
Stuart A. ArbuckleDirector2,5370.01%Jun 12, 2026
Gregory NordenDirector1,5590.01%Jun 12, 2026
Dean J. MitchellDirector18,6220.07%Jun 12, 2026
Jeffrey ChodakewitzDirector1,3710.00%Jun 12, 2026
Robert Atchinson10% owner2,374,0858.50%Oct 17, 2025
Phillip Gross10% owner2,080,1687.45%Oct 17, 2025
Adage Capital Management, L.P.10% owner––Oct 17, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Marcio Souza
Chief Executive Officer, Director
Jul 8, 2026Gift−2,600––0
Marcio Souza
Chief Executive Officer, Director
Jul 8, 2026Gift−20,521––56,495
Jill DeSimone
Director
Jun 24, 2026Sale(10b5-1 plan)−120$303.13$36.38K13,807
Jill DeSimone
Director
Jun 24, 2026Sale(10b5-1 plan)−320$305.31$97.70K13,487
Jill DeSimone
Director
Jun 24, 2026Sale(10b5-1 plan)−683$306.77$209.52K12,804
Jill DeSimone
Director
Jun 24, 2026Sale(10b5-1 plan)−1,240$308.24$382.22K11,564
Jill DeSimone
Director
Jun 24, 2026Sale(10b5-1 plan)−999$309.38$309.07K10,565
Jill DeSimone
Director
Jun 24, 2026Sale(10b5-1 plan)−1,750$310.89$544.06K8,815
Jill DeSimone
Director
Jun 24, 2026Sale(10b5-1 plan)−2,854$311.91$890.19K5,961
Jill DeSimone
Director
Jun 24, 2026Sale(10b5-1 plan)−1,004$312.83$314.08K4,957
Jill DeSimone
Director
Jun 24, 2026Sale(10b5-1 plan)−504$313.66$158.08K4,453
Jill DeSimone
Director
Jun 24, 2026Sale(10b5-1 plan)−837$315.71$264.25K2,337
Jill DeSimone
Director
Jun 24, 2026Sale(10b5-1 plan)−1,279$314.90$402.76K3,174
Jill DeSimone
Director
Jun 24, 2026Option exercise+8,566$44.25$379.05K10,903
Jill DeSimone
Director
Jun 24, 2026Option exercise+3,034$147.30$446.91K13,937
Jill DeSimone
Director
Jun 24, 2026Sale(10b5-1 plan)−10$301.44$3.01K13,927
Gregory Norden
Director
Jun 10, 2026Award+1,371––1,559
Stuart A. Arbuckle
Director
Jun 10, 2026Award+1,371––2,537
Jeffrey Chodakewitz
Director
Jun 10, 2026Award+1,371––1,371
Jill DeSimone
Director
Jun 10, 2026Award+1,371––2,337
Merit Ester Cudkowicz
Director
Jun 10, 2026Award+1,371––1,371
William D. Young
Director
Jun 10, 2026Award+1,371––3,269
Jeffrey B. Kindler
Director
Jun 10, 2026Award+1,371––2,537
Dean J. Mitchell
Director
Jun 10, 2026Award+1,371––18,622
Megan Sniecinski
Chief Operating Officer
May 14, 2026Award+89$167.94$14.95K28,664
Marcio Souza
Chief Executive Officer, Director
May 14, 2026Award+126$167.94$21.16K77,016
Timothy Edwin Kelly
Chief Financial Officer
May 14, 2026Award+121$167.94$20.32K31,167
Alex Nemiroff
General Counsel and Secretary
May 14, 2026Award+78$167.94$13.10K26,011
Lauren Mastrocola
Principal Accounting Officer
May 14, 2026Award+127$167.94$21.33K13,573
Jeffrey B. Kindler
Director
Feb 6, 2026Award+688––688
Jeffrey B. Kindler
Director
Feb 6, 2026Award+478––1,166
Stuart A. Arbuckle
Director
Feb 6, 2026Award+478––1,166
Stuart A. Arbuckle
Director
Feb 6, 2026Award+688––688
Megan Sniecinski
Chief Operating Officer
Jan 12, 2026Tax withholding−885$275.74$244.03K28,530
Alex Nemiroff
General Counsel and Secretary
Jan 12, 2026Tax withholding−768$275.74$211.77K25,933
Lauren Mastrocola
Principal Accounting Officer
Jan 12, 2026Tax withholding−344$275.74$94.85K13,446
Timothy Edwin Kelly
Chief Financial Officer
Jan 12, 2026Tax withholding−943$275.74$260.02K31,046
Lauren Mastrocola
Principal Accounting Officer
Jan 10, 2026Tax withholding−367$288.45$105.86K13,790
Timothy Edwin Kelly
Chief Financial Officer
Jan 10, 2026Tax withholding−1,335$288.45$385.08K31,989
Megan Sniecinski
Chief Operating Officer
Jan 10, 2026Tax withholding−1,087$288.45$313.55K29,415
Alex Nemiroff
General Counsel and Secretary
Jan 10, 2026Tax withholding−917$288.45$264.51K26,701
Marcio Souza
Chief Executive Officer, Director
Jan 10, 2026Tax withholding−4,252$288.45$1.23M76,890
Lauren Mastrocola
Principal Accounting Officer
Jan 8, 2026Award+3,750––14,157
Timothy Edwin Kelly
Chief Financial Officer
Jan 8, 2026Award+8,800––33,324
Megan Sniecinski
Chief Operating Officer
Jan 8, 2026Award+9,625––30,502
Alex Nemiroff
General Counsel and Secretary
Jan 8, 2026Award+6,875––27,618
Marcio Souza
Chief Executive Officer, Director
Jan 8, 2026Award+27,640––81,142
Timothy Edwin Kelly
Chief Financial Officer
Jan 7, 2026Tax withholding−139$292.63$40.68K24,524
Alex Nemiroff
General Counsel and Secretary
Jan 7, 2026Tax withholding−89$292.63$26.04K20,743
Lauren Mastrocola
Principal Accounting Officer
Jan 7, 2026Tax withholding−35$292.63$10.24K10,407
Marcio Souza
Chief Executive Officer, Director
Jan 7, 2026Tax withholding−405$292.63$118.52K53,502
Marcio Souza
Chief Executive Officer, Director
Dec 30, 2025Gift−400––2,600
Lauren Mastrocola
Principal Accounting Officer
Nov 20, 2025Option exercise+508$83.85$42.60K11,997
Lauren Mastrocola
Principal Accounting Officer
Nov 20, 2025Option exercise+1,557$133.65$208.09K13,554
Lauren Mastrocola
Principal Accounting Officer
Nov 20, 2025Option exercise+2,680$43.37$116.23K16,234
Lauren Mastrocola
Principal Accounting Officer
Nov 20, 2025Option exercise+207$44.40$9.19K16,441
Lauren Mastrocola
Principal Accounting Officer
Nov 20, 2025Option exercise+1,047$49.50$51.83K11,489
Lauren Mastrocola
Principal Accounting Officer
Nov 20, 2025Option exercise+2,351$44.40$104.38K18,792
Lauren Mastrocola
Principal Accounting Officer
Nov 20, 2025Option exercise+5,250$56.94$298.94K24,042
Lauren Mastrocola
Principal Accounting Officer
Nov 20, 2025Sale−11,455$191.96$2.20M12,587

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
15.18%
4M shares short
Days to cover
8.7
At 0M shares a day
Change since last report
+7.3%
From 4M shares
Short volume, 20 days
55.8%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Praxis Precision Medicines's stock actually held short. Settlement fails (shares not delivered on time) peaked at 26,972 shares on Oct 14, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Jill DeSimone
Director
Jun 24, 202611,600$3.61MJun 24, 2026Stock Option Exercise
Lauren Mastrocola
Officer
Nov 20, 202513,600$2.61MNov 20, 2025Option Granted - 09/24/2019
Alex Nemiroff
Officer
Nov 20, 202525,130$4.85MNov 20, 2025Options Granted - 07/29/2024
Lauren Mastrocola
Officer
Nov 14, 20245,189$424.32KNov 14, 2024Option Granted 07/29/2024
Alex Nemiroff
Officer
Nov 14, 20248,240$660.83KNov 14, 2024Options Granted - 07/29/2024

Congress trades

2 trades in Praxis Precision Medicines reported by 1 member of the House

MemberTypeTradedAmountFiled
Gilbert Cisneros
CA31
BoughtSep 29, 2026$1K–15KOct 12, 2026
Gilbert Cisneros
CA31
BoughtJul 30, 2026$1K–15KSep 4, 2026

See a number that looks wrong?